SLVAX
Price
$38.83
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Net Assets
2.58B
VIVIX
Price
$72.41
Change
+$0.36 (+0.50%)
Updated
Oct 17 closing price
Net Assets
207.8B
Interact to see
Advertisement

SLVAX vs VIVIX

Header iconSLVAX vs VIVIX Comparison
Open Charts SLVAX vs VIVIXBanner chart's image
Columbia Select Large Cap Value A
Price$38.83
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets2.58B
Vanguard Value Index I
Price$72.41
Change+$0.36 (+0.50%)
VolumeN/A
Net Assets207.8B
SLVAX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
SLVAX vs. VIVIX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLVAX is a Hold and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 208B vs. SLVAX (2.58B). VIVIX pays higher dividends than SLVAX: VIVIX (2.09) vs SLVAX (1.48). SLVAX was incepted earlier than VIVIX: SLVAX (29 years) vs VIVIX (27 years). SLVAX (1.07) is less costly to investors than VIVIX (0.04). SLVAX is a more actively managed with annual turnover of: 28.00 vs. VIVIX (9.00). SLVAX has a lower initial minimum investment than VIVIX: SLVAX (2000) vs VIVIX (5000000). SLVAX annual gain was more profitable for investors over the last year : 11.00 vs. VIVIX (3.99). VIVIX (70.92) and SLVAX (70.25) have equivalent 5 years return.
SLVAXVIVIXSLVAX / VIVIX
Total Expense Ratio0.850.042,125%
Annual Report Gross Expense Ratio1.070.042,675%
Fund Existence29 years27 years-
Gain YTD17.6679.202192%
Front Load6%N/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.58B208B1%
Annual Yield % from dividends1.482.0971%
Returns for 1 year11.003.99276%
Returns for 3 years49.4244.12112%
Returns for 5 years70.2570.9299%
Returns for 10 years97.82128.1876%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN23.010.74
+3.32%
Viridian Therapeutics
NHPAP17.84-0.14
-0.78%
National Healthcare Properties Inc
CCRN12.85-0.20
-1.53%
Cross Country Healthcare
BZ21.50-0.50
-2.27%
Kanzhun Limited
LICN4.35-0.22
-4.81%
Lichen International Limited